検索結果 185 件
JaLCDOI | 10.18926/AMO/59961 |
---|---|
フルテキストURL | 74_3_261.pdf |
著者 | Nakahara, Keiichi| Ikeda, Tokunori| Takamatsu, Koutaro| Tawara, Nozomu| Hara, Kentaro| Enokida, Yuki| Tanoue, Naomi| Narita, Sawana| Fujii, Akiko| Yamanouchi, Yoshinori| Morinaga, Jun| Yamashita, Satoshi| |
抄録 | Muscle biopsy can be used to confirm the diagnosis of neuromuscular diseases. However, it is unclear whether antibiotic prophylaxis prior to muscle biopsy is needed to prevent surgical site infection (SSI). We are conducting a phase 2, single-center, open-labeled, prospective randomized trial to clarify the need for antibiotic prophylaxis in patients at low risk for SSI undergoing muscle biopsy. Patients will be randomized to an antibiotic prophylaxis group or a control group, and the incidence of SSI will be compared between the groups. Our findings will clarify the need for antibiotic prophylaxis in this patient population. |
キーワード | muscle biopsy antibiotic prophylaxis |
Amo Type | Clinical Study Protocol |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-06 |
巻 | 74巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 261 |
終了ページ | 264 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32577026 |
Web of Science KeyUT | 000543363400011 |
NAID | 120006862802 |
JaLCDOI | 10.18926/AMO/59960 |
---|---|
フルテキストURL | 74_3_257.pdf |
著者 | Hongo, Takashi| Ikeda, Fusao| Fujioka, Shinichi| Akatsuka, Riku| Fujiwara, Tosifumi| Yamamoto, Kazuhide| |
抄録 | A 65-year-old Japanese woman developed vesicular eruptions on her right ear due to varicella zoster virus (VZV) reactivation, followed by cranial polyneuritis and meningitis affecting her right cranial nerves V, VII, VIII, IX, and X. After acyclovir administration, her facial paralysis worsened. Intravenous methylprednisolone and vitamin C were administered on Day 4 post-admission. Her symptoms steadily improved, and by Day 45 she had fully recovered. Cranial polyneuritis is a rare complication of VZV reactivation, and there is no established method of treatment. This is the first report of full recovery from cranial polyneuritis using intravenous vitamin C as ancillary treatment. |
キーワード | varicella zoster virus polyneuritis vitamin C meningitis facial nerve palsy |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-06 |
巻 | 74巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 257 |
終了ページ | 260 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32577025 |
Web of Science KeyUT | 000543363400010 |
NAID | 120006862801 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Yamada, Keiko| Ito, Yoichi M.| Akagi, Masao| Chosa, Etsuo| Fuji, Takeshi| Hirano, Kenichi| Ikeda, Shinichi| Ishibashi, Hideaki| Ishibashi, Yasuyuki| Ishijima, Muneaki| Itoi, Eiji| Iwasaki, Norimasa| Izumida, Ryoichi| Kadoya, Ken| Kamimura, Masayuki| Kanaji, Arihiko| Kato, Hiroyuki| Kishida, Shunji| Mashima, Naohiko| Matsuda, Shuichi| Matsui, Yasumoto| Matsunaga, Toshiki| Miyakoshi, Naohisa| Mizuta, Hiroshi| Nakamura, Yutaka| Nakata, Ken| Omori, Go| Osuka, Koji| Uchio, Yuji| Ryu, Kazuteru| Sasaki, Nobuyuki| Sato, Kimihito| Senda, Masuo| Sudo, Akihiro| Takahira, Naonobu| Tsumura, Hiroshi| Yamaguchi, Satoshi| Yamamoto, Noriaki| Nakamura, Kozo| Takashi, Ohe| |
発行日 | 2020-03-12 |
出版物タイトル | Journal of Orthopaedic Science |
出版者 | Elsevier |
ISSN | 09492658 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © 2020 The Authors. |
論文のバージョン | publisher |
PubMed ID | 32173180 |
DOI | 10.1016/j.jos.2020.01.011 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Marti, Ll.| Ikeda, M.| Kato, Y.| Kishimoto, Y.| Nakahata, M.| Nakajima, Y.| Nakano, Y.| Nakayama, S.| Okajima, Y.| Orii, A.| Pronost, G.| Sekiya, H.| Shiozawa, M.| Tanaka, H.| Ueno, K.| Yamada, S.| Yano, T.| Yokozawa, T.| Murdoch, M.| Schuemann, J.| Vagins, M.R.| Bays, K.| Carminati, G.| Griskevich, N.J.| Kropp, W.R.| Locke, S.| Renshaw, A.| Smy, M.B.| Weatherly, P.| Ito, S.| Ishino, H.| Kibayashi, A.| Koshio, Y.| Mori, T.| Sakuda, M.| Yamaguchi, R.| Fernandez, P.| Labarga, L.| Bandac, I.| Perez, J.| Amey, J.| Litchfield, R.P.| Sztuc, A.| Uchida, Y.| Ma, W.Y.| Goldsack, A.| Simpson, C.| Wark, D.| Anthony, L.H.V.| McCauley, N.| Pritchard, A.| Di Lodovico, F.| Richards, B.| Cole, A.| Thiesse, M.| Thompson, L.| Imber, J.| Cao, S.V.| Ito, K.| Takeuchi, Y.| Akutsu, R.| Nishimura, Y.| Okumura, K.| Hirota, S.| Muto, F.| Yokoyama, M.| Suda, Y.| Zhang, H.| |
発行日 | 2020-04-11 |
出版物タイトル | Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment |
巻 | 959巻 |
出版者 | Elsevier |
開始ページ | 163549 |
ISSN | 01689002 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © 2020 The Authors. Published by Elsevier B.V. |
論文のバージョン | publisher |
DOI | 10.1016/j.nima.2020.163549 |
Web of Science KeyUT | 000518368800020 |
関連URL | isVersionOf 10.1016/j.nima.2020.163549 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Kanazawa, Mai| Ikeda, Yoko| Nishihama, Ryuichi| Yamaoka, Shohei| Lee, Nam-Hee| Yamato, Katsuyuki T| Kohchi, Takayuk| Hirayama, Takashi| |
キーワード | Arabidopsis Marchantia polymorpha Mitochondria Poly(A) polymerase Poly(A) regulation Poly(A)-specific ribonuclease |
備考 | This is a pre-copyedited, author-produced version of an article accepted for publication in Plant and Cell Physiology following peer review. The version of record Mai Kanazawa et. al. Regulation of the Poly(A) Status of Mitochondrial mRNA by Poly(A)-Specific Ribonuclease Is Conserved among Land Plants. Plant and Cell Physiology 61(3), 470–480 (2020) is available online at: https://doi.org/10.1093/pcp/pcz212. | |
発行日 | 2019-11-13 |
出版物タイトル | Plant and Cell Physiology |
巻 | 61巻 |
号 | 3号 |
出版者 | Oxford University Press |
開始ページ | 470 |
終了ページ | 480 |
ISSN | 00320781 |
NCID | AA0077511X |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | author |
PubMed ID | 31722408 |
DOI | 10.1093/pcp/pcz212 |
Web of Science KeyUT | 000522855600004 |
関連URL | isVersionOf https://doi.org/10.1093/pcp/pcz212 |
JaLCDOI | 10.18926/AMO/58267 |
---|---|
フルテキストURL | 74_2_103.pdf |
著者 | Kawada, Yasumasa| Kubo, Toru| Baba, Yuichi| Hirota, Takayoshi| Tanioka, Katsutoshi| Yamasaki, Naohito| Kitaoka, Hiroaki| |
抄録 | This study examined whether switching from amlodipine and atorvastatin treatment using two pills to an equal dose of single-pill therapy is useful in Japanese outpatients. We retrospectively reviewed data obtained from 94 outpatients for whom treatment with two pills, namely amlodipine and atorvastatin, was switched to an equal dose of single-pill therapy in 11 hospitals. The criterion for enrollment in this study was that patients had switched their medication without changing other anti-hypertensive or anti-cholesterol drugs. Neither systolic nor diastolic blood pressure changed significantly after switching to an equal dose of single-pill therapy, whereas low-density lipoprotein (LDL) cholesterol levels significantly decreased after the medication was switched from 94±24 mg/dl to 89±17 mg/dl (p=0.015). A switch from medication with two separate pills of amlodipine and atorvastatin to an equal dose of single-pill therapy resulted in an overall decrease in LDL cholesterol. The results indicated that the switch to single-pill therapy might be a useful treatment. |
キーワード | hypertension dyslipidemia single-pill therapy |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-04 |
巻 | 74巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 103 |
終了ページ | 108 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32341583 |
Web of Science KeyUT | 000528278500002 |
NAID | 120006839446 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Ito, S.| Okada, T.| Takaku, Y.| Harada, M.| Ikeda, M.| Kishimoto, Y.| Koshio, Y.| Nakahata, M.| Nakajima, Y.| Sekiya, H.| |
発行日 | 2019-06-29 |
出版物タイトル | Progress of Theoretical and Experimental Physics |
号 | 6号 |
出版者 | Oxford University Press |
開始ページ | 063H03 |
ISSN | 2050-3911 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2019. |
論文のバージョン | publisher |
DOI | 10.1093/ptep/ptz060 |
Web of Science KeyUT | 000482307100015 |
関連URL | isVersionOf https://doi.org/10.1093/ptep/ptz060 |
JaLCDOI | 10.18926/AMO/57955 |
---|---|
フルテキストURL | 74_1_65.pdf |
著者 | Akiyama, Tomoyuki| Saigusa, Daisuke| Hyodo, Yuki| Umeda, Keiko| Saijo, Reina| Koshiba, Seizo| Kobayashi, Katsuhiro| |
抄録 | To characterize metabolic profiles within the central nervous system in epilepsy, we performed gas chromatography-tandem mass spectrometry (GC-MS/MS)-based metabolome analysis of the cerebrospinal fluid (CSF) in pediatric patients with and without epilepsy. The CSF samples obtained from 64 patients were analyzed by GC-MS/MS. Multivariate analyses were performed for two age groups, 0-5 years of age and 6-17 years of age, to elucidate the effects of epilepsy and antiepileptic drugs on the metabolites. In patients aged 0-5 years (22 patients with epilepsy, 13 without epilepsy), epilepsy patients had reduced 2-ketoglutaric acid and elevated pyridoxamine and tyrosine. In patients aged 6-17 years (12 with epilepsy, 17 without epilepsy), epilepsy patients had reduced 1,5-anhydroglucitol. Valproic acid was associated with elevated 2-aminobutyric acid, 2-ketoisocaproic acid, 4-hydroxyproline, acetylglycine, methionine, N-acetylserine, and serine. Reduced energy metabolism and alteration of vitamin B6 metabolism may play a role in epilepsy in young children. The roles of 1,5-anhydroglucitol in epilepsy in older children and in levetiracetam and zonisamide treatment remain to be explained. Valproic acid influenced the levels of amino acids and related metabolites involved in the metabolism of serine, methionine, and leucine. |
キーワード | antiepileptic drugs gas chromatography-tandem mass spectrometry metabolome analysis metabolomics |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-02 |
巻 | 74巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 65 |
終了ページ | 72 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32099251 |
Web of Science KeyUT | 000516606200010 |
NAID | 120006795622 |
フルテキストURL | SR9_1_11934.pdf |
---|---|
著者 | Takahara, Masahiro| Takaki, Akinobu| Hiraoka, Sakiko| Adach, Takuya| Shimomura, Yasuyuki| Matsushita, Hiroshi| Nguyen Tien Thi Thuy| Koike, Kazuko| Ikeda, Airi| Takashima, Shiho| Yamasaki, Yasushi| Inokuchi, Toshihiro| Kinugasa, Hideaki| Sugihara, Yusaku| Harada, Keita| Eikawa, Shingo| Morita, Hidetoshi| Udono, Heiichiro| Okada, Hiroyuki| |
発行日 | 2019-8-15 |
出版物タイトル | Scientific Reports |
巻 | 9巻 |
出版者 | Nature Publishing Group |
開始ページ | 11934 |
ISSN | 2045-2322 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2019 |
論文のバージョン | publisher |
PubMed ID | 31417110 |
DOI | 10.1038/s41598-019-48331-w |
Web of Science KeyUT | 000480680800048 |
関連URL | isVersionOf https://doi.org/10.1038/s41598-019-48331-w |
JaLCDOI | 10.18926/AMO/57720 |
---|---|
フルテキストURL | 73_6_537.pdf |
著者 | Takahara, Yasuhiro| Nishida, Keiichiro| Nakashima, Hirotaka| Ochi, Nobuaki| Uchida, Yoichiro| Kato, Hisayoshi| Itani, Satoru| Nakamura, Makoto| Iwasaki, Yuichi| Tsujimura, Yoshitaka| |
抄録 | High tibial osteotomy (HTO) procedure is generally contraindicated in rheumatoid arthritis (RA) patients because synovial inflammation may exacerbate joint damage post-surgery. The natural course of joint destruction in RA changed dramatically with new treatment strategies and the introduction of biologic disease-modifying anti-rheumatic drugs (bDMARDs). We report the cases of two RA patients who underwent HTO and whose disease activities were well controlled by bDMARDs. Despite their short follow-up periods, they showed acceptable objective and subjective clinical results. We believe that the combination of bDMARDs and HTO can be indicated for selected RA patients before total knee arthroplasty. |
キーワード | high tibial osteotomy rheumatoid arthritis biologic DMARD knee surgery |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-12 |
巻 | 73巻 |
号 | 6号 |
出版者 | Okayama University Medical School |
開始ページ | 537 |
終了ページ | 542 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31871338 |
Web of Science KeyUT | 000503431400011 |
JaLCDOI | 10.18926/AMO/57375 |
---|---|
フルテキストURL | 73_5_441.pdf |
著者 | Watanabe, Toshiyuki| Sakurai, Toru| Mukai, Yuko| Kimata, Yoshihiro| Namba, Yuzaburo| |
抄録 | Gender dysphoria is a condition in which a discrepancy between biological sex and gender identity causes distress. Many female-to-male transsexuals (FTMTS) are uncomfortable with female breasts. Chest wall contouring surgery is effective for obtaining a male-type chest, reducing mental stress, and increasing sexual satisfaction in such cases. At the Okayama University Hospital Gender Center, we have obtained positive results using an algorithm to determine the most appropriate surgical method for chest wall contouring in FTMTS patients. However, serious complications requiring reoperation, such as hematoma, may still occur. Postoperative hematomas were found in 15 (4.18%) of 358 FTMTS patients who underwent chest contouring surgery at our hospital between 2006 and 2018. Postoperative hematoma was examined retrospectively. The median time to the onset of hematoma was 7 (6-12) h after the initial surgery. The main blood vessels causing bleeding were those in the head-side skin flap region where visual confirmation was difficult and the perforator vessels from the pectoralis major muscle. Intraoperative bleeding and the operation time had a significant impact on the onset of postoperative hematoma. This is the first retrospective study that investigated the blood vessels and other factors contributing to postoperative hematoma development after chest wall contouring. |
キーワード | female-to-male transsexuals chest wall contouring postoperative hematoma |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-10 |
巻 | 73巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 441 |
終了ページ | 447 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31649371 |
Web of Science KeyUT | 000491886600010 |
JaLCDOI | 10.18926/AMO/57368 |
---|---|
フルテキストURL | 73_5_387.pdf |
著者 | Inoue, Miyabi| Yokoyama, Teruhiko| |
抄録 | To assess the efficacy and safety of 2 drugs for overactive bladder (OAB), solifenacin and mirabegron. Fortyseven female OAB patients were randomized into 2 groups. Twenty-three patients were initially prescribed solifenacin for 4 weeks, followed by mirabegron for 4 weeks (group S). The other 24 patients were initially prescribed mirabegron for 4 weeks, followed by solifenacin for 4 weeks (group M). Evaluations included clinical determination of the OAB symptom score (OABSS), International Prostate Symptom Score (IPSS), and Visual Analog Scale. The IPSS significantly improved after the administration of solifenacin in both groups. The OABSS significantly improved in both groups after 4 weeks. In group M, the OABSS after eight weeks was significantly improved compared to that after 4 weeks. However, in group S, it was not significantly improved. Twelve patients experienced adverse events during the solifenacin treatment, while 2 patients experienced adverse events during the mirabegron treatment. Both solifenacin and mirabegron led to improved OAB symptoms. Switching from mirabegron to solifenacin significantly improved the OABSS. However, mirabegron led to fewer adverse events than solifenacin. We recommend that mirabegron be prescribed first for OAB patients. If patients are not satisfied with mirabegron, solifenacin should be used. |
キーワード | overactive bladder, randomized crossover study solifenacin mirabegron |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-10 |
巻 | 73巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 387 |
終了ページ | 392 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31649364 |
Web of Science KeyUT | 000491886600003 |
JaLCDOI | 10.18926/AMO/56940 |
---|---|
フルテキストURL | 73_4_367.pdf |
著者 | Mifune-Morioka, Tomoyo| A. Uchida, Haruhito| Fukushima, Kazuhiko| Watanabe, Mayu| Ouchi, Chihiro| Mise, Koki| Kawakita, Chieko| Kano, Yuzuki| Onishi, Akifumi| Toma, Kishio| Eguchi, Jun| Wada, Nozomu| Ikeda, Fusao| Sasaki, Erika| Suganami, Yu| Kishida, Masayuki| Sugiyama, Hitoshi| Okada, Hiroyuki| Wada, Jun| |
抄録 | Eight years prior to her present admission, a 61-year-old Japanese woman was diagnosed with autoimmune hepatitis, slowly progressive insulin-dependent diabetes mellitus, and chronic thyroiditis; she had been treated with oral prednisolone (PSL). After she suddenly discontinued PSL, she newly developed systemic lupus erythematosus. A combination therapy of oral PSL and intravenous cyclophosphamide resulted in remission. She was finally diagnosed with autoimmune polyglandular syndrome (APS) type 3 (3A ,3B, 3D), complicated with four different autoimmune diseases. Since patients with type 3 APS may present many manifestations over a long period of time, they should be carefully monitored. |
キーワード | autoimmune polyglandular syndrome type 3 systemic lupus erythematosus autoimmune hepatitis slowly progressive insulin-dependent diabetes mellitus chronic thyroiditis |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-08 |
巻 | 73巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 367 |
終了ページ | 372 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31439961 |
JaLCDOI | 10.18926/AMO/56935 |
---|---|
フルテキストURL | 73_4_333.pdf |
著者 | Kuwaki, Kenji| Nouso, Kazuhiro| Miyashita, Manabi| Makino, Yasuhiro| Hagihara, Hiroaki| Moriya, Akio| Adachi, Takuya| Wada, Nozomu| Yasunaka, Yuki| Yasunaka, Tetsuya| Takeuchi, Yasuto| Onishi, Hideki| Nakamura, Shinichiro| Ikeda, Fusao| Shiraha, Hidenori| Takaki, Akinobu| Okada, Hiroyuki| |
抄録 | Steroids are often administered at the time of transcatheter arterial chemoembolization (TACE), a standard treatment of hepatocellular carcinoma (HCC), with the expectation of preventing postembolization syndrome. Here we investigated the precise effects of steroids on TACE. We prospectively enrolled 144 HCC patients from 10 hospitals who underwent TACE. Three hospitals used steroids (steroid group, n=77) and the rest did not routinely use steroids (control group, n=67). The occurrence of adverse events and the algetic degree at 1-5 days post-treatment were compared between the groups. Fever (grades 0-2) after TACE was significantly less in the steroid group (56/21/0) compared to the control group (35/29/3, p=0.005, Cochran-Armitage test for trend). The suppressive effect of steroids against fever was prominent in females (p=0.001). Vomiting (G0/G1/ G2-) was also less frequent in the steroid group (70/5/2) versus the control group (53/10/3), but not significantly (p=0.106). The algetic degree and the grade of hematological adverse events, including hyperglycemia, did not differ between the groups. We conclude that the administration of steroids was useful for the prevention of adverse events after TACE in patients with HCC. |
キーワード | antipyretic hepatocellular carcinoma therapeutic chemoembolization steroid |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-08 |
巻 | 73巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 333 |
終了ページ | 339 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31439956 |
JaLCDOI | 10.18926/AMO/56464 |
---|---|
フルテキストURL | 73_1_85.pdf |
著者 | Abe, Yoshiyuki| Fujibayashi, Kazutoshi| Nishizaki, Yuji| Yanagisawa, Naotake| Nojiri, Shuko| Nakano, Soichiro| Tada, Kurisu| Yamaji, Ken| Tamura, Naoto| |
抄録 | Pneumocystis pneumonia (PCP) due to Pneumocystis jirovecii infection is the leading cause of fatal opportunistic infections in immunocompromised patients. We will determine whether a daily sulfamethoxazole-trimethoprim (SMX/TMP) dose of 200/40 mg was non-inferior to 400/80 mg for PCP prevention in patients with systemic rheumatic disease under immunosuppressive therapy. This is a randomized, open-label, multicenter controlled trial. The primary outcome is the rate of PCP prevention at 52 weeks. The secondary outcome is the discontinuation rate of SMX/TMP. The trial will evaluate the optimal dose of SMX/TMP for PCP prevention in patients with systemic rheumatic disease under immunosuppressive therapy. |
キーワード | pneumocystis pneumonia prophylaxis systemic rheumatic disease sulfamethoxazole-trimethoprim conventional-dose versus half-dose |
Amo Type | Clinical Study Protocol |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 85 |
終了ページ | 89 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820060 |
JaLCDOI | 10.18926/AMO/56463 |
---|---|
フルテキストURL | 73_1_81.pdf |
著者 | Sugihara, Yuusaku| Harada, Keita| Oka, Shohei| Yasutomi, Eriko| Yamasaki, Yasushi| Inokuchi, Toshihiro| Kinugasa, Hideaki| Takahara, Masahiro| Hiraoka, Sakiko| Otsuka, Fumio| Okada, Hiroyuki| |
抄録 | Endoscopic submucosal dissection (ESD) is reportedly one of the standard treatment strategies for large superficial colorectal neoplasms in Japan because of its high en bloc resection rate. A few technical issues regarding ESD should be considered, one of which is the selection of the Endo-cut I mode versus the Swift-coagulation mode as the electrosurgical unit mode setting during submucosal dissection. We seek to determine which of these two modes is more suitable for submucosal dissections of colorectal tumors with regard to procedure time and safety. |
キーワード | endoscopic submucosal dissection electrosurgical mode colorectal tumor |
Amo Type | Clinical Study Protocol |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 81 |
終了ページ | 84 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820059 |
JaLCDOI | 10.18926/AMO/56457 |
---|---|
フルテキストURL | 73_1_43.pdf |
著者 | Ikeda, Ailee| Takaki, Akinobu| Yasunaka, Tetsuya| Oyama, Atsushi| Adachi, Takuya| Wada, Nozomu| Onishi, Hideki| Ikeda, Fusao| Shiraha, Hidenori| Yoshida, Kazuhiro| Kuise, Takashi| Nobuoka, Daisuke| Yoshida, Ryuichi| Umeda, Yuzo| Yagi, Takahito| Fujiwara, Toshiyoshi| Okada, Hiroyuki| |
抄録 | Post-orthotopic liver transplantation (OLT) hepatitis B recurrence is well-controlled with a nucleos(t)ide analogue and hepatitis B immunoglobulin (HBIG) combination, but the high cost and the potential risk of unknown infection associated with HBIG remain unresolved issues. Low-cost recombinant hepatitis B virus (HBV) vaccine administration is a potential solution to these problems. We retrospectively analyzed the rate and predictive factors of HBV vaccine success in 49 post-OLT patients: liver cirrhosis-type B (LC-B), n=28 patients; acute liver failure-type B (ALF-B), n=8; and non-HBV-related end-stage liver disease (non-B ESLD) who received a liver from anti-hepatitis B core antibody-positive donors, n=13. A positive anti-hepatitis B surface antibody response was achieved in 29% (8/28) of the LC-B group, 88% (7/8) of the ALF-B group, and 44% (4/9) of the adult non-B ESLD group. All four non-B ESLD infants showed vaccine success. The predictive factors for a good response in LC-B were young age, marital donor, and high donor age. ALF-B and non-B ESLD infants are thus good vaccination candidates. LC-B patients with marital donors are also good candidates, perhaps because the donated liver maintains an efficient immune memory to HBV, as the donors had already been infected in adulthood and showed adequate anti-HBV immune responses. |
キーワード | acute liver failure hepatitis B hepatitis B vaccine liver cirrhosis liver transplantation |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 41 |
終了ページ | 50 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820053 |
JaLCDOI | 10.18926/AMO/56456 |
---|---|
フルテキストURL | 73_1_29.pdf |
著者 | Matsumoto, Atsushi| Nakamura, Takehiro| Shinomiya, Aya| Kawakita, Kenya| Kawanishi, Masahiko| Miyake, Keisuke| Kuroda, Yasuhiro| Keep, Richard F.| Tamiya, Takashi| |
抄録 | Cerebral vasospasm (CVS) is a major contributor to the high morbidity and mortality of aneurysmal subarachnoid hemorrhage (aSAH) patients. We measured histidine-rich glycoprotein (HRG), a new biomarker of aSAH, in cerebrospinal fluid (CSF) to investigate whether HRG might be an early predictor of CVS. A total of seven controls and 14 aSAH patients (8 males, 6 females aged 53.4±15.4 years) were enrolled, and serial CSF and serum samples were taken. We allocated these samples to three phases (T1-T3) and measured HRG, interleukin (IL)-6, fibrinopeptide A (FpA), and 8-hydroxy-2’-deoxyguanosine (8OHdG) in the CSF, and the HRG in serum. We also examined the release of HRG in rat blood incubated in artificial CSF. In contrast to the other biomarkers examined, the change in the CSF HRG concentration was significantly different between the nonspasm and spasm groups (p<0.01). The rat blood/CSF model revealed a time course similar to that of the human CSF samples in the non-spasm group. HRG thus appears to have the potential to become an early predictor of CVS. In addition, the interaction of HRG with IL-6, FpA, and 8OHdG may form the pathology of CVS. |
キーワード | biomarker histidine-rich glycoprotein predictor subarachnoid hemorrhage vasospasm |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 29 |
終了ページ | 39 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820052 |
JaLCDOI | 10.18926/AMO/56455 |
---|---|
フルテキストURL | 73_1_21.pdf |
著者 | Oiwa, Yuko| Watanabe, Toyohiko| Sadahira, Takuya| Ishii, Ayano| Sako, Tomoko| Inoue, Miyabi| Wada, Koichiro| Kobayashi, Yasuyuki| Araki, Motoo| Nasu, Yasutomo| |
抄録 | We measured basal clitoral blood flow by Doppler sonography to determine whether tension-free vaginal mesh(TVM) affects the clitoral blood flow and sexual function in women with pelvic organ prolapse (POP). We performed a prospective study of 22 patients who underwent TVM for POP. Clitoral blood flow was measured by Doppler ultrasound. The resistance index (RI), pulsatility index (PI), peak systolic velocity (PSV), and end-diastolic velocity (EDV) of the clitoral arteries were measured preoperatively and at 1, 3, and 6 months postoperatively. Female sexual function was also investigated with the Female Sexual Function Index (FSFI). The mean PI and RI were increased at 1 month and significantly decreased at 6 months postoperatively (p<0.05). In contrast, the mean PSV and EDV decreased at 1 month postoperatively and increased at 6 months postoperatively. These four parameters recovered to baseline levels at 6 months following surgery. Total FSFI scores improved significantly from 10.2±7.9 at baseline to 18.2±8.9 at 6 months postoperatively. Color Doppler ultrasonography is potentially useful in measuring clitoral blood flow in patients treated with TVM for POP. Prospective long-term studies are needed to evaluate the utility of this modality as a diagnostic and prognostic tool for female sexual dysfunction. |
キーワード | clitoris pelvic organ prolapse Doppler ultrasound |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 21 |
終了ページ | 27 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820051 |
JaLCDOI | 10.18926/AMO/56452 |
---|---|
フルテキストURL | 73_1_1.pdf |
著者 | Morizane, Shin| |
抄録 | Excessive protease activity is a characteristic abnormality that affects the epidermal barrier in patients with atopic dermatitis (AD). Kallikrein-related peptidases (KLKs) are excessively expressed in AD lesions, and it is suggested that the abnormal action of KLKs is involved in the skin barrier dysfunction in AD. In other words, overexpressed KLKs disrupt the normal barrier function, and due to that breakdown, external substances that can become antigens of AD easily invade the epidermis, resulting in dermatitis, coupled with the induction of Th2 cytokines. Further investigations are required to elucidate the role of KLKs in AD; this knowledge could contribute to the design of new therapeutic and prophylactic drugs for AD. |
キーワード | atopic dermatitis kallikrein-related peptidases epidermal barrier dysfunction |
Amo Type | Review |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 1 |
終了ページ | 6 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820048 |